1. Integrated High-throughput Transcriptomic Data Identifies Survivin as a Potential Breast Cancer Therapeutic Biomarker
   Zeenat Mirza, 2024, Current Medicinal Chemistry CrossRef
2. Sensitive Imaging of Cellular RNA via Cascaded Proximity-Induced Fluorogenic Reactions
   Zhiyan Chen et al, 2022, ACS Applied Materials & Interfaces CrossRef
3. Antimalarial N1,N3-Dialkyldioxonaphthoimidazoliums: Synthesis, Biological Activity, and Structure–activity Relationships
   Stephen Ahenkorah et al, 2020, ACS Medicinal Chemistry Letters CrossRef
4. Association of survivin splice variants with prognosis and treatment of breast cancer
   Anastasia Pavlidou, 2014, World Journal of Clinical Oncology CrossRef
5. Quinone-Based Antitumor Agent Sepantronium Bromide (YM155) Causes Oxygen-Independent Redox-Activated Oxidative DNA Damage
   Tasaduq H. Wani et al, 2018, Chemical Research in Toxicology CrossRef
6. Prognostic Significance of BIRC5/Survivin in Breast Cancer: Results from Three Independent Cohorts
   Nina Oparina et al, 2021, Cancers CrossRef
7. Small Molecules Targeting Programmed Cell Death in Breast Cancer Cells
   Subashani Maniam et al, 2021, International Journal of Molecular Sciences CrossRef
8. Cellular, transcriptomic and isoform heterogeneity of breast cancer cell line revealed by full-length single-cell RNA sequencing
   Shaocheng Wu et al, 2020, Computational and Structural Biotechnology Journal CrossRef
9. Novel Survivin Peptides Screened With Computer Algorithm Induce Cytotoxic T Lymphocytes With Higher Cytotoxic Efficiency to Cancer Cells
   Qiuqiang Chen et al, 2020, Frontiers in Molecular Biosciences CrossRef